Introduction :

Dolphin Pharmaceuticals is a leading Denosumab supplier from India, based in Surat, Gujarat, specializing in the supply of high-quality specialty medicines. We serve pharmacy, distributors, hospitals, and healthcare organizations worldwide with quality-assured Denosumab.

Denosumab is primarily used for the treatment of osteoporosis under the supervision of qualified healthcare professionals. Dolphin Pharmaceuticals is committed to providing authentic medicines, competitive pricing, complete support, global healthcare requirements.

Esentra Injection:

Esentra (Denosumab) is a prescription biologic medicine manufactured by Intas Pharmaceuticals Ltd. It belongs to the class of monoclonal antibodies and RANK ligand (RANKL) inhibitors and is used for the treatment of osteoporosis in eligible patients at increased risk of fractures, as well as certain bone-related conditions depending on the strength and approved indication. Denosumab works by blocking RANKL, a protein involved in the formation and activity of osteoclasts, the cells responsible for bone breakdown. This helps reduce bone loss, increase bone mineral density, and lower the risk of fractures. It is administered by subcutaneous injection under medical supervision, with calcium levels monitored during treatment, particularly in patients with kidney disease.

Product Introduction

Esentra Injection contains denosumab, a monoclonal antibody used to treat osteoporosis and reduce the risk of fractures in eligible patients. It works by slowing down bone breakdown, helping maintain bone mineral density and strengthening bones. Depending on the product strength and approved indication, denosumab is also used for bone loss associated with certain cancer treatments and other conditions affecting bone health.

Denosumab Injection is administered subcutaneously (under the skin) by a qualified healthcare professional. The dosage and frequency depend on the condition being treated and the prescribed formulation. For osteoporosis, denosumab is generally administered once every six months. Adequate calcium and vitamin D intake is important during treatment, and supplementation may be recommended by your doctor.

Common side effects may include back pain, joint pain, muscle pain, pain in the arms or legs, and increased cholesterol levels. Some patients may experience infections, skin reactions, or low calcium levels in the blood. Rare but serious complications include osteonecrosis of the jaw and atypical thigh bone fractures. Patients with severe kidney disease or those undergoing dialysis are at increased risk of severe hypocalcaemia and require careful monitoring.

Before starting treatment, inform your doctor about any kidney problems, low calcium levels, dental issues, planned dental procedures, or other medicines you are taking. Maintain good oral hygiene and attend recommended dental check-ups. Do not stop or delay denosumab treatment without medical advice, as discontinuation can lead to rapid bone loss and an increased risk of vertebral fractures. Your doctor may prescribe another medicine if treatment is stopped.

Uses of Denosumab Injection

• Treatment of osteoporosis in eligible patients at increased risk of fractures.

• Management of bone loss associated with certain medical conditions or treatments, depending on the approved indication and formulation.

Benefits of Denosumab Injection

Treatment of Osteoporosis

Osteoporosis is a condition in which bones become weak and fragile, increasing the risk of fractures. Denosumab Injection helps slow bone breakdown, increase bone mineral density, and strengthen bones. This can reduce the risk of fractures, including those affecting the spine and other bones, in appropriately selected patients.

Side Effects of Denosumab Injection

Possible side effects include:

• Back pain

• Pain in the arms or legs

• Joint and muscle pain

• Increased cholesterol levels

• Urinary tract infections

• Nasopharyngitis (inflammation of the nose and throat)

• Headache

• Low blood calcium levels

Seek prompt medical attention if you experience muscle spasms, tingling around the mouth, severe weakness, jaw pain, or unusual thigh or groin pain.

How Denosumab Injection Works

Esentra contains denosumab, a monoclonal antibody that targets a protein called RANKL (receptor activator of nuclear factor-kappa B ligand). RANKL stimulates the formation and activity of osteoclasts, the cells responsible for breaking down bone tissue. By blocking RANKL, denosumab reduces osteoclast activity, slows bone resorption, and helps increase bone density and strength.